Synthetic DNA-encoded checkpoint inhibitor antibodies advance cancer immunotherapy
Thursday, October 4, 2018 - 18:30
in Health & Medicine
Scientists demonstrate for the first time that through engineering constructs, they can express DNA-encoded monoclonal antibodies (DMAbs) targeting CTLA-4, an important cancer checkpoint molecule that blocks anti-cancer immunity.